CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
CTIC
Delisted
CTIC was delisted on the 23rd of June, 2023.
38 hedge funds and large institutions have $33.7M invested in CTI BioPharma Corp. (DE) Common Stock in 2020 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 4 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
-2
Holders Change %
-5%
% of All Funds
0.84%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
7
Increased
12
Reduced
4
Closed
6
Calls
$32K
Puts
–
Net Calls
+$32K
Net Calls Change
-$157K
Top Buyers
1 |
O
OrbiMed
New York
|
+$4.16M |
2 |
NMC
NEA Management Company
Timonium,
Maryland
|
+$3.12M |
3 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$2.46M |
4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$583K |
5 |
CC
Caxton Corporation
Princeton,
New Jersey
|
+$268K |
Top Sellers
1 |
![]()
JPMorgan Chase & Co
New York
|
-$144K |
2 |
Two Sigma Investments
New York
|
-$28.4K |
3 |
Connor, Clark & Lunn Investment Management (CC&L)
Vancouver,
British Columbia, Canada
|
-$25K |
4 |
Goldman Sachs
New York
|
-$21K |
5 |
Morgan Stanley
New York
|
-$11.1K |